InspireMD Inc. (NSPR)

Business: InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific.

IPO Date: 12-Apr-2011

Pres, CEO & Director: Mr. Marvin L. Slosman

CFO, Chief Admin. Officer, Sec. & Treasurer: Mr. Craig Shore

Listing: NASDAQ: NSPR

Country: Israel

Headquarters: Tel Aviv,

Website: https://www.inspiremd.com

Market cap: $16.98 Mln

Revenue (TTM): $4.67 Mln

Earnings (TTM): $-16.16 Mln

Cash: $29.85 Mln

Total Debt: $1.09 Mln

Insider's Holding: 9.19%

Liquidity: Low

52 Week range: $1.80 - 6.82

Shares outstanding: 8,323,200

10 Years Aggregate:

• CFO: $-92.61 Mln
• EBITDA: $-122.39 Mln
• Net Profit: $-131.42 Mln